{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:45:25Z","timestamp":1788583525568,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150640","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T18:58:53Z","timestamp":1457463533000},"page":"e0150640","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials"],"prefix":"10.1371","volume":"11","author":[{"given":"Phillip","family":"Zaworski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine M.","family":"von Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Sunshine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Risher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Weetall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Paushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,8]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal Muscular Atrophy","volume":"33","author":"SJ Kolb","year":"2015","journal-title":"Neurol Clin"},{"issue":"5\u20136","key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA Consortium Meeting (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"TL Munsat","year":"1992","journal-title":"Neuromuscular Disorders"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","article-title":"Observational study of spinal muscular atrophy type I and implications for clinical trials","volume":"83","author":"RS Finkel","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","article-title":"A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients","volume":"146","author":"K Zerres","year":"1997","journal-title":"J Neurol Sci"},{"key":"ref5","article-title":"Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician's Approach","author":"BT Darras","year":"2015"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy: Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"K Zerres","year":"1995","journal-title":"Arch Neurol"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00415-008-0929-0","article-title":"A natural history study of late onset spinal muscular atrophy types 3b and 4","volume":"255","author":"S Piepers","year":"2008","journal-title":"J Neurol"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"CL Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.neuint.2004.04.005","article-title":"Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin\/proteasome pathway","volume":"45","author":"H Chang","year":"2004","journal-title":"Neurochem Int"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gad.1884910","article-title":"A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity","volume":"24","author":"S Cho","year":"2010","journal-title":"Genes Dev"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"BG Burnett","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"6197","key":"ref12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"NA Naryshkin","year":"2014","journal-title":"Science"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"J Palacino","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1083\/jcb.201207087","article-title":"Antisense-based therapy for the treatment of spinal muscular atrophy","volume":"199","author":"F Rigo","year":"2012","journal-title":"J Cell Biol"},{"issue":"23","key":"ref15","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy","volume":"35","author":"S Tisdale","year":"2015","journal-title":"Journal of Neuroscience"},{"issue":"18","key":"ref16","first-page":"1","article-title":"Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics","volume":"1","author":"KV Bricceno","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/hmg\/ddr360","article-title":"Reversible molecular pathology of skeletal muscle in spinal muscular atrophy","volume":"20","author":"Ca Mutsaers","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yexcr.2005.08.019","article-title":"Hypomorphic Smn knockdown C2C12 myoblasts reveal intrinsic defects in myoblast fusion and myotube morphology","volume":"311","author":"D Shafey","year":"2005","journal-title":"Exp Cell Res"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"e0139950","DOI":"10.1371\/journal.pone.0139950","article-title":"Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls","volume":"10","author":"C Czech","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/adt.2015.635","article-title":"Detection of survival motor neuron protein in buccal cells through electrochemiluminescence-based assay","volume":"13","author":"H Steinkellner","year":"2015","journal-title":"Assay Drug Dev Technol"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"e24269","DOI":"10.1371\/journal.pone.0024269","article-title":"Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses","volume":"6","author":"DT Kobayashi","year":"2011","journal-title":"PLoS ONE"},{"issue":"14","key":"ref22","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","article-title":"A novel nuclear structure containing the survival of motor neurons protein","volume":"15","author":"Q Liu","year":"1996","journal-title":"EMBO J"},{"key":"ref23","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation Draft Guidance. September 2013."},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"PE McAndrew","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"20","key":"ref25","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1093\/hmg\/dds285","article-title":"Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models","volume":"21","author":"M Osborne","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"e33572","DOI":"10.1371\/journal.pone.0033572","article-title":"Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study","volume":"7","author":"TO Crawford","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"e50763","DOI":"10.1371\/journal.pone.0050763","article-title":"Evaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron protein","volume":"7","author":"DT Kobayashi","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"S Lefebvre","year":"1997","journal-title":"Nat Genet"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"TW Prior","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/ejhg.2012.233","article-title":"Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study","volume":"21","author":"FD Tiziano","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","article-title":"Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets","volume":"122","author":"MM Denis","year":"2005","journal-title":"Cell"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acn3.283","article-title":"Baseline Results of the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study","volume":"3","author":"SJ Kolb","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI72017","article-title":"Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation","volume":"124","author":"S Kariya","year":"2014","journal-title":"J Clin Invest"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:35:15Z","timestamp":1588991715000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150640"}},"subtitle":[],"editor":[{"given":"Ravindra N","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,8]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150640","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,8]]}}}